We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-21.79%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$2.63B
AUM Growth
-$1.11B
Cap. Flow
-$123M
Cap. Flow %
-4.66%
Top 10 Hldgs %
51.48%
Holding
146
New
29
Increased
20
Reduced
29
Closed
45

Top Buys

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$123M
2
AMRN
Amarin Corp
AMRN
+$77.8M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$47.7M
4
ALLO icon
Allogene Therapeutics
ALLO
+$41M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$39M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$72M
2
CORI
Corium International, Inc.
CORI
+$60.5M
3
ECYT
Endocyte, Inc. Common Stock
ECYT
+$43.4M
4
ISRG icon
Intuitive Surgical
ISRG
+$41.6M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$37.2M

Sector Composition

Rank Sector Weight
1 Healthcare 97.94%
2 Miscellaneous 1.24%
3 Consumer Staples 0.68%
4 Financials 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAPR icon
101
Capricor Therapeutics
CAPR
$498M
– –
-400
Closed -$4K
CASI
102
DELISTED
CASI Pharmaceuticals
CASI
– –
-4,368
Closed -$204K
EVH icon
103
Evolent Health
EVH
$423M
– –
-110,000
Closed -$3.12M
GERN icon
104
CALL
Geron
GERN
$842M
– –
-200,000
Closed -$10K
GERN icon
105
PUT
Geron
GERN
$842M
– –
-1,950,000
Closed -$3.68M
HCM icon
106
HUTCHMED
HCM
$2.4B
– –
-10,000
Closed -$322K
HUM icon
107
Humana
HUM
$47.6B
– –
-35,000
Closed -$11.8M
IRTC icon
108
iRhythm Holdings
IRTC
$3.69B
– –
-168,939
Closed -$16M
ISRG icon
109
Intuitive Surgical
ISRG
$133B
– –
-217,500
Closed -$41.6M
KNSA icon
110
Kiniksa Pharmaceuticals
KNSA
$5.86B
– –
-53,169
Closed -$1.36M
LIVN icon
111
LivaNova
LIVN
$4.38B
– –
-111,000
Closed -$13.8M
MDGL icon
112
Madrigal Pharmaceuticals
MDGL
$12.1B
– –
-2,213
Closed -$474K
NTRA icon
113
Natera
NTRA
$50.6B
– –
-24,000
Closed -$575K
OCGN icon
114
Ocugen
OCGN
$337M
– –
-20,057
Closed -$656K
PTCT icon
115
PTC Therapeutics
PTCT
$5.48B
– –
-19,367
Closed -$910K
SENS icon
116
Senseonics Holdings Inc
SENS
$470M
– –
-5,750
Closed -$549K
SNDA icon
117
Sonida Senior Living
SNDA
$1.91B
– –
-6,678
Closed -$946K
STIM icon
118
Neuronetics
STIM
$213M
– –
-135,500
Closed -$4.34M
TARA icon
119
Protara Therapeutics
TARA
$222M
– –
-6,012
Closed -$469K
VKTX icon
120
Viking Therapeutics
VKTX
$3.49B
– –
-64,261
Closed -$1.12M
XERS icon
121
Xeris Biopharma Holdings
XERS
$1.37B
– –
-200,627
Closed -$3.53M
ONC
122
BeOne Medicines Ltd
ONC
$39.2B
– –
-5,700
Closed -$982K
GTHX
123
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-14,055
Closed -$735K
MRNS
124
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-226,933
Closed -$9.08M
DMK
125
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-1,964
Closed -$481K
2 3 4
5
6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Perceptive Advisors held 146 positions worth $2.63B, down 30% from $3.74B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Perceptive Advisors withdrew a net $123M in Q4 2018, closing 45 positions and reducing 29 holdings. Its most notable exit was Corium International, Inc., an estimated $60.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 93% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Solid Biosciences worth $105M.

  • Perceptive Advisors's largest Q4 2018 buy was Solid Biosciences: 261,815 shares worth $105M.
  • Perceptive Advisors added most to Amarin Corp in Q4 2018, an estimated $77.8M increase.
  • Perceptive Advisors's biggest Q4 2018 reduction was Alnylam Pharmaceuticals, cutting an estimated $72M.
  • Perceptive Advisors fully exited Corium International, Inc. in Q4 2018, selling an estimated $60.5M.
  • Perceptive Advisors's ten largest holdings make up 51% of its $2.63B portfolio in Q4 2018.
  • Perceptive Advisors opened 29 new positions and closed 45 in Q4 2018.
  • Perceptive Advisors's portfolio value fell 30% quarter-over-quarter to $2.63B.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.